Is Diamondback Energy a Good Stock to Buy?
Diamondback Energy (FANG) is a lesser-known diamond in the rough…
Buy
68
SBMFF Quote, Financials, Valuation and Earnings
Last price:
$0.45
Seasonality move
:
-1.16%
Day range:
$0.45 - $0.45
52-week range:
$0.31 - $0.47
Dividend yield:
2.3%
P/E ratio:
16.73x
P/S ratio:
2.03x
P/B ratio:
1.85x
Volume:
--
Avg. volume:
233
1-year change:
22.76%
Market cap:
$8.1B
Revenue:
$4B
EPS (TTM):
$0.03
Earnings Data
Next earnings date for SBMFF
Aug 13
2025
Most recent earnings per share
$0.01
Beat by $0.01
(Mar 23/2021)
Consensus Estimate
--
(Mar 23/2021)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SBMFF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2021 | Q4 | -- | -- | $0.01 | -- | -- |
| 11/30/2020 | Q3 | -- | -- | $0.00 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | $0.00 | -- | -- |
| 04/21/2020 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.00 | -- | -- |
| 11/26/2019 | Q3 | -- | -- | $0.01 | -- | -- |
| 09/27/2019 | Q2 | -- | -- | $0.00 | -- | -- |
| 05/21/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.05 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | $0.00 | -- | -- |
Sino Biopharmaceutical Earnings Questions
-
How Much did Sino Biopharmaceutical Generate in Revenue Last Quarter?
Sino Biopharmaceutical reported -- worth of top line sales in its most recent quarter.
-
Did Sino Biopharmaceutical Beat Earnings Last Quarter?
Sino Biopharmaceutical announced earnings per share of $0.01 which represents a beat of analyst forecast a -- per share.
-
Is Sino Biopharmaceutical Profitable?
Sino Biopharmaceutical reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sino Biopharmaceutical EPS Next Year?
Sino Biopharmaceutical's earnings are forecast to grow from $0.03 per share to -- per share next year representing an increase of --.
-
When is Sino Biopharmaceutical's Earnings Date?
Sino Biopharmaceutical's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
29
UNF alert for Mar 26
UniFirst [UNF] is up 0.24% over the past day.
Sell
30
KEQU alert for Mar 26
Kewaunee Scientific [KEQU] is down 1.45% over the past day.
Buy
82
EPAC alert for Mar 26
Enerpac Tool Group [EPAC] is down 3.19% over the past day.
